Members and witnesses warn funding disruption is slowing treatment, research and community health services
Loading...
Summary
Members and witnesses said a recent executive action and OMB memo that froze federal disbursements disrupted NIH, SAMHSA, Medicaid flows and community health centers, delaying grants, meetings and services used for prevention, treatment and research.
Several members and witnesses told the subcommittee that administrative actions this month — including an OMB memorandum directing a temporary funding freeze and related communications restrictions — disrupted grant disbursements, federal advisory meetings and clinical-research funding, with immediate impacts on prevention and treatment programs.
Ranking Member Diana DeGette described calls from Colorado providers and researchers who reported frozen payments to health systems and delayed NIH-funded research. "I got a call from my daughter ... they couldn't get the CDC guidance on birth control or on vaccines," DeGette said in opening remarks; she and other members linked the disruptions to operational confusion at hospitals and research centers.
Regina LaBelle, who serves on the National Advisory Council on Drug Abuse, told the committee that a scheduled advisory council meeting was canceled with little notice and that grant-signing activity could be delayed while the agency sorts requirements. "We were supposed to have a meeting on Tuesday. I received an email at 8 a.m. saying it was canceled," she said.
Members and witnesses cited concrete downstream impacts: community health centers reported delayed federal payments, some centers temporarily unable to access routine grants, and potential interruptions to SAMHSA funding that supports overdose-prevention programming. Several members cited press reports and state notifications that some federally qualified health centers faced disruption or closure while payments were unavailable.
Ending: Committee members urged prompt resolution of federal payment pathways and recommended Congress monitor and, where necessary, reinforce channels that deliver grant and Medicaid funding for prevention, treatment and research.
